Literature DB >> 21925592

Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2.

Alexandra Kadl1, Poonam R Sharma, Wenshu Chen, Rachana Agrawal, Akshaya K Meher, Swetha Rudraiah, Nathaniel Grubbs, Rahul Sharma, Norbert Leitinger.   

Abstract

Oxidative tissue damage is a hallmark of many chronic inflammatory diseases. However, the precise mechanisms linking oxidative changes to inflammatory reactions remain unclear. Herein we show that Toll-like receptor 2 (TLR2) translates oxidative tissue damage into inflammatory responses by mediating the effects of oxidized phospholipids. Intraperitoneal injection of oxidized 1-palmitoyl-2-arachidonyl-sn-3-glycerophosphorylcholine (OxPAPC) resulted in upregulation of inflammatory genes in wild-type, but not in TLR2(-/-) mice. In vitro, OxPAPC induced TLR2 (but not TLR4)-dependent inflammatory gene expression and JNK and p38 signaling in macrophages. Induction of TLR2-dependent gene expression required reducible functional groups on sn-2 acyl chains of oxidized phospholipids, as well as serum cofactors. Finally, TLR2(-/-) mice were protected against carbon tetrachloride-induced oxidative tissue damage and inflammation, which was accompanied by accumulation of oxidized phospholipids in livers. Together, our findings demonstrate that TLR2 mediates cellular responses to oxidative tissue damage and they provide new insights into how oxidative stress is linked to acute and chronic inflammation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925592      PMCID: PMC3197756          DOI: 10.1016/j.freeradbiomed.2011.08.026

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  48 in total

1.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands.

Authors:  Xiaoxia Z West; Nikolay L Malinin; Alona A Merkulova; Mira Tischenko; Bethany A Kerr; Ernest C Borden; Eugene A Podrez; Robert G Salomon; Tatiana V Byzova
Journal:  Nature       Date:  2010-10-03       Impact factor: 49.962

2.  A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids.

Authors:  Sangderk Lee; Nima M Gharavi; Henry Honda; Irene Chang; Brandon Kim; Nelson Jen; Rongsong Li; Alejandro Zimman; Judith A Berliner
Journal:  Free Radic Biol Med       Date:  2009-04-16       Impact factor: 7.376

Review 3.  Nrf2:INrf2 (Keap1) signaling in oxidative stress.

Authors:  James W Kaspar; Suryakant K Niture; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2009-08-07       Impact factor: 7.376

4.  Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

Authors:  Alexandra Kadl; Akshaya K Meher; Poonam R Sharma; Monica Y Lee; Amanda C Doran; Scott R Johnstone; Michael R Elliott; Florian Gruber; Jenny Han; Wenshu Chen; Thomas Kensler; Kodi S Ravichandran; Brant E Isakson; Brian R Wamhoff; Norbert Leitinger
Journal:  Circ Res       Date:  2010-07-22       Impact factor: 17.367

5.  Induction of CCR2-dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation.

Authors:  Alexandra Kadl; Elena Galkina; Norbert Leitinger
Journal:  Arthritis Rheum       Date:  2009-05

6.  Tlr2 is critical for diet-induced metabolic syndrome in a murine model.

Authors:  Ryan W Himes; C Wayne Smith
Journal:  FASEB J       Date:  2009-10-19       Impact factor: 5.191

Review 7.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

8.  TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.

Authors:  Michael G Drage; Nicole D Pecora; Amy G Hise; Maria Febbraio; Roy L Silverstein; Douglas T Golenbock; W Henry Boom; Clifford V Harding
Journal:  Cell Immunol       Date:  2009-04-11       Impact factor: 4.868

9.  Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.

Authors:  Elena von Schlieffen; Olga V Oskolkova; Gernot Schabbauer; Florian Gruber; Stephan Blüml; Melinda Genest; Alexandra Kadl; Claudia Marsik; Sylvia Knapp; Jesse Chow; Norbert Leitinger; Bernd R Binder; Valery N Bochkov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-26       Impact factor: 8.311

10.  Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell.

Authors:  Sangderk Lee; Rongsong Li; Brandon Kim; Roland Palvolgyi; Tiffany Ho; Qian-Zhou Yang; Jason Xu; Wan Lam Szeto; Henry Honda; Judith A Berliner
Journal:  J Lipid Res       Date:  2008-08-29       Impact factor: 5.922

View more
  56 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

2.  Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.

Authors:  Young Sup Byun; Jun-Hee Lee; Benoit J Arsenault; Xiaohong Yang; Weihang Bao; David DeMicco; Rachel Laskey; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

3.  TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion.

Authors:  Thibaut Quillard; Haniel Alves Araújo; Gregory Franck; Eugenia Shvartz; Galina Sukhova; Peter Libby
Journal:  Eur Heart J       Date:  2015-03-08       Impact factor: 29.983

4.  Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.

Authors:  Amir Ravandi; Gregor Leibundgut; Ming-Yow Hung; Mitul Patel; Patrick M Hutchins; Robert C Murphy; Anand Prasad; Ehtisham Mahmud; Yury I Miller; Edward A Dennis; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2014-03-05       Impact factor: 24.094

5.  Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.

Authors:  Ming Jin; Lin Wang; Yan Wu; Bao-Xia Zang; Li Tan
Journal:  Chin J Integr Med       Date:  2018-01-03       Impact factor: 1.978

6.  Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed Apoe-/- Mice.

Authors:  Olga A Cherepanova; Prasad Srikakulapu; Elizabeth S Greene; Malay Chaklader; Ryan M Haskins; Mary E McCanna; Smarajit Bandyopadhyay; Bhupal Ban; Norbert Leitinger; Coleen A McNamara; Gary K Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-24       Impact factor: 8.311

Review 7.  Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.

Authors:  Gregor Leibundgut; Joseph L Witztum; Sotirios Tsimikas
Journal:  Curr Opin Pharmacol       Date:  2013-03-28       Impact factor: 5.547

Review 8.  Role of phospholipid oxidation products in atherosclerosis.

Authors:  Sangderk Lee; Konstantin G Birukov; Casey E Romanoski; James R Springstead; Aldons J Lusis; Judith A Berliner
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

Review 9.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

Review 10.  Oxidized cholesteryl esters and inflammation.

Authors:  Soo-Ho Choi; Dmitri Sviridov; Yury I Miller
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-06-29       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.